These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22341909)

  • 1. Serum prolactin level in patients with relapsing-remitting multiple sclerosis during relapse.
    Moshirzadeh S; Ghareghozli K; Harandi AA; Pakdaman H
    J Clin Neurosci; 2012 Apr; 19(4):622-3. PubMed ID: 22341909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum prolactin level in patients with multiple sclerosis: a case control study.
    Harirchian MH; Sahraian MA; Shirani A
    Med Sci Monit; 2006 Apr; 12(4):CR177-80. PubMed ID: 16572053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and cerebrospinal fluid prolactin levels in male and female patients with clinically-isolated syndrome or relapsing-remitting multiple sclerosis.
    Markianos M; Koutsis G; Evangelopoulos ME; Mandellos D; Sfagos C
    J Neuroendocrinol; 2010 Jun; 22(6):503-8. PubMed ID: 20236233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum uric acid level in patients with relapsing-remitting multiple sclerosis.
    Ashtari F; Bahar M; Aghaei M; Zahed A
    J Clin Neurosci; 2013 May; 20(5):676-8. PubMed ID: 23528410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperprolactinemia in males with systemic lupus erythematosus.
    Mok CC; Lau CS; Lee KW; Wong RW
    J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine profile, Foxp3 and nuclear factor-kB ligand levels in multiple sclerosis subtypes.
    Alatab S; Maghbooli Z; Hossein-Nezhad A; Khosrofar M; Mokhtari F
    Minerva Med; 2011 Dec; 102(6):461-8. PubMed ID: 22193377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated HSP27 levels during attacks in patients with multiple sclerosis.
    Ce P; Erkizan O; Gedizlioglu M
    Acta Neurol Scand; 2011 Nov; 124(5):317-20. PubMed ID: 21208199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered diurnal rhythm of prolactin in systemic sclerosis.
    Hilty C; Brühlmann P; Sprott H; Gay RE; Michel BA; Gay S; Neidhart M
    J Rheumatol; 2000 Sep; 27(9):2160-5. PubMed ID: 10990228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum anti-Glc(alpha1,4)Glc(alpha) antibodies as a biomarker for relapsing-remitting multiple sclerosis.
    Schwarz M; Spector L; Gortler M; Weisshaus O; Glass-Marmor L; Karni A; Dotan N; Miller A
    J Neurol Sci; 2006 May; 244(1-2):59-68. PubMed ID: 16480743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycoplasma pneumonia seroposivity in Iranian patients with relapsing-remitting multipl sclerosis: a randomized case-control study.
    Bahar M; Ashtari F; Aghaei M; Akbari M; Salari M; Ghalamkari S
    J Pak Med Assoc; 2012 Mar; 62(3 Suppl 2):S6-8. PubMed ID: 22768448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of sTNFR-1 and sFas in patients with relapsing-remitting multiple sclerosis.
    Bilińska M; Frydecka I; Podemski R; Gruszka E
    Med Sci Monit; 2002 Oct; 8(10):CR720-3. PubMed ID: 12388926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with multiple sclerosis have higher levels of serum ghrelin.
    Berilgen MS; Bulut S; Ustundag B; Tekatas A; Ayar A
    Neuro Endocrinol Lett; 2005 Dec; 26(6):819-22. PubMed ID: 16380704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
    Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
    Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin is Not Associated with Disability and Clinical Forms in Patients with Multiple Sclerosis.
    de Carvalho Jennings Pereira WL; Flauzino T; Alfieri DF; Oliveira SR; Kallaur AP; Simão ANC; Lozovoy MAB; Kaimen-Maciel DR; Maes M; Reiche EMV
    Neuromolecular Med; 2020 Mar; 22(1):73-80. PubMed ID: 31473879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of hyperprolactinemia in patients with primary Sjögren's syndrome.
    Haga HJ; Rygh T
    J Rheumatol; 1999 Jun; 26(6):1291-5. PubMed ID: 10381045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta.
    Boz C; Ozmenoglu M; Velioglu S; Kilinc K; Orem A; Alioglu Z; Altunayoglu V
    Clin Neurol Neurosurg; 2006 Feb; 108(2):124-8. PubMed ID: 16412833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases.
    Brettschneider J; Jaskowski TD; Tumani H; Abdul S; Husebye D; Seraj H; Hill HR; Fire E; Spector L; Yarden J; Dotan N; Rose JW
    J Neuroimmunol; 2009 Dec; 217(1-2):95-101. PubMed ID: 19879655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis.
    Frisullo G; Nociti V; Iorio R; Patanella AK; Marti A; Caggiula M; Mirabella M; Tonali PA; Batocchi AP
    Cytokine; 2008 Oct; 44(1):22-5. PubMed ID: 18793860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study.
    Saida T; Tashiro K; Itoyama Y; Sato T; Ohashi Y; Zhao Z;
    Neurology; 2005 Feb; 64(4):621-30. PubMed ID: 15728282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon beta therapy increases serum ferritin levels in patients with relapsing-remitting multiple sclerosis.
    Sena A; Pedrosa R; Ferret-Sena V; Cascais MJ; Roque R; Araújo C; Couderc R
    Mult Scler; 2008 Jul; 14(6):857-9. PubMed ID: 18573825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.